[Cephalexin monohydrate in infections of the soft and superficial tissues].
D000038:Abscess / Q000188:drug therapy; D000328:Adult; D000368:Aged; D000977:Antiparasitic Agents; D002511:Cephalosporins / Q000009:adverse effects / Q000627:therapeutic use*; D004756:Enterobacteriaceae Infections / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007710:Klebsiella Infections / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D010000:Osteitis / Q000188:drug therapy; D011512:Proteus Infections / Q000188:drug therapy; D013203:Staphylococcal Infections / Q000188:drug therapy
D000977:Antiparasitic Agents; D002511:Cephalosporins
El monohidrato de cefalexina en infecciones de tejidos blandos superficiales.